Financial reviews and presentations

Orion will publish Interim Report for January–March 2021 on Tuesday, 27 April 2021 approximately at 12.00 noon EEST. The release and related presentation material as well as link to the live webcast and teleconference details will be available here after publishing.

Read more

AGM 2021

The Annual General Meeting of Orion Corporation was held on Thursday 25 March 2021 at Orion's Head Office in Espoo. The decisions and related material are available here.

Read more

CMD 2021

Orion’s virtual Capital Markets Day 2021 for investors, analysts and media will be held on 26 May 2021 at 1.00 p.m – 4.00 p.m. EEST.

Read more

Financial Statements

Orion Group's Financial Statement documents for 2020 are available here.

Read more

Corporate Governance Statement

The latest Corporate Governance Statement of Orion Corporation is available at the archive of Corporate Governance Statements.

Read more

Stock Exchange Releases

3/25/2021 Orion Corporation: Organising meeting of the Board of Directors
3/25/2021 Decisions taken by Orion Corporation’s Annual General Meeting on 25 March 2021
3/3/2021 Change to the Notice of Orion Corporation’s Annual General Meeting
3/2/2021 Orion Group Financial Statement documents 2020, Corporate Governance Statement and Remuneration Report published

Press Releases

4/12/2021 Orion publishes Interim Report for January–March 2021 on Tuesday 27 April 2021
3/15/2021 Save the date – Orion’s Virtual Capital Markets Day on 26 May 2021 at 1.00 p.m. – 4.00 p.m. EEST
2/8/2021 Orion and Bayer expand development program for darolutamide in prostate cancer
1/20/2021 Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021

Share information

Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.

Read more

Major shareholders by votes

Monthly updated list of Orion's major shareholders by votes.

Read more

Orion's R&D Pipeline

Read more
Research 

Orion Executive Management Board

The members of the Board of Directors

Orion included in FTSE4Good Index

Orion Corporation has been included in the globally recognised FTSE4Good Index.

Read more

Our approach to corporate responsibility

Orion aims to grow faster than the pharmaceutical market

Research and development are Orion's strengths, and the company will continue to invest in them. The target is to increase net sales 1.5-fold by 2025.

Read more

Investing benefits both investors and society

Responsibility is one incentive when retail investors seek investments. Pharmaceuticals and healthcare is one of the most interesting sectors.

Read more
Orion's century
About Orion
Products and Services
Investors
FAQ
Media
Corporate Governance
AGM
Contact us